PortalPublikationenConsensus of German transplant centers on hematopoietic stem...

Consensus of German transplant centers on hematopoietic stem cell transplantation in Fanconi anemia

Standard

Consensus of German transplant centers on hematopoietic stem cell transplantation in Fanconi anemia. / Chao, M M; Ebell, W; Bader, P; Beier, R; Burkhardt, B; Feuchtinger, T; Handgretinger, R; Hanenberg, H; Koehl, U; Kratz, C; Kremens, B; Lang, P; Meisel, R; Müller, Ingo; Roessig, C; Sauer, M; Schlegel, P G; Schulz, A; Strahm, B; Thol, F; Sykora, K W.

in: KLIN PADIATR, Jahrgang 227, Nr. 3, 05.2015, S. 157-65.

Publikationen: SCORING: Beitrag in Fachzeitschrift/Zeitung › SCORING: Zeitschriftenaufsatz › Forschung › Begutachtung

Harvard

Chao, MM, Ebell, W, Bader, P, Beier, R, Burkhardt, B, Feuchtinger, T, Handgretinger, R, Hanenberg, H, Koehl, U, Kratz, C, Kremens, B, Lang, P, Meisel, R, Müller, I, Roessig, C, Sauer, M, Schlegel, PG, Schulz, A, Strahm, B, Thol, F & Sykora, KW 2015, 'Consensus of German transplant centers on hematopoietic stem cell transplantation in Fanconi anemia', KLIN PADIATR, Jg. 227, Nr. 3, S. 157-65. https://doi.org/10.1055/s-0035-1548841

APA

Chao, M. M., Ebell, W., Bader, P., Beier, R., Burkhardt, B., Feuchtinger, T., Handgretinger, R., Hanenberg, H., Koehl, U., Kratz, C., Kremens, B., Lang, P., Meisel, R., Müller, I., Roessig, C., Sauer, M., Schlegel, P. G., Schulz, A., Strahm, B., ... Sykora, K. W. (2015). Consensus of German transplant centers on hematopoietic stem cell transplantation in Fanconi anemia. KLIN PADIATR, 227(3), 157-65. https://doi.org/10.1055/s-0035-1548841

Vancouver

Chao MM, Ebell W, Bader P, Beier R, Burkhardt B, Feuchtinger T et al. Consensus of German transplant centers on hematopoietic stem cell transplantation in Fanconi anemia. KLIN PADIATR. 2015 Mai;227(3):157-65. https://doi.org/10.1055/s-0035-1548841

Bibtex

@article{078d7c62fac14394a6c89b6a84eb54ae,
title = "Consensus of German transplant centers on hematopoietic stem cell transplantation in Fanconi anemia",
abstract = "Allogeneic hematopoietic stem cell transplantation (HSCT) is currently the only curative therapy for the severe hematopoietic complications associated with Fanconi anemia (FA). In Germany, it is estimated that 10-15 transplants are performed annually for FA. However, because FA is a DNA repair disorder, standard conditioning regimens confer a high risk of excessive regimen-related toxicities and mortality, and reduced intensity regimens are linked with graft failure in some FA patients. Moreover, development of graft-versus-host disease is a major contributing factor for secondary solid tumors. The relative rarity of the disorder limits HSCT experience at any single center. Consensus meetings were convened to develop a national approach for HSCT in FA. This manuscript outlines current experience and knowledge about HSCT in FA and, based on this analysis, general recommendations reached at these meetings.",
author = "Chao, {M M} and W Ebell and P Bader and R Beier and B Burkhardt and T Feuchtinger and R Handgretinger and H Hanenberg and U Koehl and C Kratz and B Kremens and P Lang and R Meisel and Ingo M{\"u}ller and C Roessig and M Sauer and Schlegel, {P G} and A Schulz and B Strahm and F Thol and Sykora, {K W}",
note = "{\textcopyright} Georg Thieme Verlag KG Stuttgart · New York.",
year = "2015",
month = may,
doi = "10.1055/s-0035-1548841",
language = "English",
volume = "227",
pages = "157--65",
journal = "KLIN PADIATR",
issn = "0300-8630",
publisher = "Georg Thieme Verlag KG",
number = "3",

}

RIS

TY - JOUR

T1 - Consensus of German transplant centers on hematopoietic stem cell transplantation in Fanconi anemia

AU - Chao, M M

AU - Ebell, W

AU - Bader, P

AU - Beier, R

AU - Burkhardt, B

AU - Feuchtinger, T

AU - Handgretinger, R

AU - Hanenberg, H

AU - Koehl, U

AU - Kratz, C

AU - Kremens, B

AU - Lang, P

AU - Meisel, R

AU - Müller, Ingo

AU - Roessig, C

AU - Sauer, M

AU - Schlegel, P G

AU - Schulz, A

AU - Strahm, B

AU - Thol, F

AU - Sykora, K W

N1 - © Georg Thieme Verlag KG Stuttgart · New York.

PY - 2015/5

Y1 - 2015/5

N2 - Allogeneic hematopoietic stem cell transplantation (HSCT) is currently the only curative therapy for the severe hematopoietic complications associated with Fanconi anemia (FA). In Germany, it is estimated that 10-15 transplants are performed annually for FA. However, because FA is a DNA repair disorder, standard conditioning regimens confer a high risk of excessive regimen-related toxicities and mortality, and reduced intensity regimens are linked with graft failure in some FA patients. Moreover, development of graft-versus-host disease is a major contributing factor for secondary solid tumors. The relative rarity of the disorder limits HSCT experience at any single center. Consensus meetings were convened to develop a national approach for HSCT in FA. This manuscript outlines current experience and knowledge about HSCT in FA and, based on this analysis, general recommendations reached at these meetings.

AB - Allogeneic hematopoietic stem cell transplantation (HSCT) is currently the only curative therapy for the severe hematopoietic complications associated with Fanconi anemia (FA). In Germany, it is estimated that 10-15 transplants are performed annually for FA. However, because FA is a DNA repair disorder, standard conditioning regimens confer a high risk of excessive regimen-related toxicities and mortality, and reduced intensity regimens are linked with graft failure in some FA patients. Moreover, development of graft-versus-host disease is a major contributing factor for secondary solid tumors. The relative rarity of the disorder limits HSCT experience at any single center. Consensus meetings were convened to develop a national approach for HSCT in FA. This manuscript outlines current experience and knowledge about HSCT in FA and, based on this analysis, general recommendations reached at these meetings.

U2 - 10.1055/s-0035-1548841

DO - 10.1055/s-0035-1548841

M3 - SCORING: Journal article

C2 - 25985449

VL - 227

SP - 157

EP - 165

JO - KLIN PADIATR

JF - KLIN PADIATR

SN - 0300-8630

IS - 3

ER -